Updating guidance for preventing and treating cryptococcal disease: how evidence and decisions interface

Cochrane Database Syst Rev. 2018 Nov 30;11(11):ED000130. doi: 10.1002/14651858.ED000130.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adrenal Cortex Hormones / therapeutic use
  • Adult
  • Amphotericin B / therapeutic use
  • Anti-HIV Agents / supply & distribution
  • Anti-HIV Agents / therapeutic use
  • Antifungal Agents / therapeutic use*
  • Antigens, Fungal / analysis
  • Child
  • Cryptococcus / immunology
  • Deoxycholic Acid / therapeutic use
  • Drug Combinations
  • Fluconazole / therapeutic use
  • Flucytosine / therapeutic use
  • HIV Infections / complications*
  • HIV Infections / drug therapy
  • Humans
  • Maintenance Chemotherapy
  • Meningitis, Cryptococcal / diagnosis*
  • Meningitis, Cryptococcal / drug therapy*
  • Meningitis, Cryptococcal / etiology
  • Meningitis, Cryptococcal / prevention & control*
  • Practice Guidelines as Topic*
  • World Health Organization

Substances

  • Adrenal Cortex Hormones
  • Anti-HIV Agents
  • Antifungal Agents
  • Antigens, Fungal
  • Drug Combinations
  • Deoxycholic Acid
  • Amphotericin B
  • amphotericin B, deoxycholate drug combination
  • Fluconazole
  • Flucytosine